162 related articles for article (PubMed ID: 12836073)
1. Intermediate filament nestin expressions in human cord blood monocytes (HCMNCs).
Ha Y; Lee JE; Kim KN; Cho YE; Yoon DH
Acta Neurochir (Wien); 2003 Jun; 145(6):483-7. PubMed ID: 12836073
[TBL] [Abstract][Full Text] [Related]
2. Fetal human hematopoietic stem cells can differentiate sequentially into neural stem cells and then astrocytes in vitro.
Hao HN; Zhao J; Thomas RL; Parker GC; Lyman WD
J Hematother Stem Cell Res; 2003 Feb; 12(1):23-32. PubMed ID: 12662433
[TBL] [Abstract][Full Text] [Related]
3. WNT-conditioned media differentially affect the proliferation and differentiation of cord blood-derived CD133+ cells in vitro.
Nikolova T; Wu M; Brumbarov K; Alt R; Opitz H; Boheler KR; Cross M; Wobus AM
Differentiation; 2007 Feb; 75(2):100-11. PubMed ID: 17316380
[TBL] [Abstract][Full Text] [Related]
4. Somatic stem cell marker prominin-1/CD133 is expressed in embryonic stem cell-derived progenitors.
Kania G; Corbeil D; Fuchs J; Tarasov KV; Blyszczuk P; Huttner WB; Boheler KR; Wobus AM
Stem Cells; 2005; 23(6):791-804. PubMed ID: 15917475
[TBL] [Abstract][Full Text] [Related]
5. Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines.
Veselska R; Hermanova M; Loja T; Chlapek P; Zambo I; Vesely K; Zitterbart K; Sterba J
BMC Cancer; 2008 Oct; 8():300. PubMed ID: 18925963
[TBL] [Abstract][Full Text] [Related]
6. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
Li MW; Niu CS
Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD133 and other putative stem cell markers in uveal melanoma.
Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
[TBL] [Abstract][Full Text] [Related]
8. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia.
Ying Z; Gonzalez-Martinez J; Tilelli C; Bingaman W; Najm I
Epilepsia; 2005 Nov; 46(11):1716-23. PubMed ID: 16302851
[TBL] [Abstract][Full Text] [Related]
9. The epigenetic regulation of stem cell factors in hepatic stellate cells.
Reister S; Kordes C; Sawitza I; Häussinger D
Stem Cells Dev; 2011 Oct; 20(10):1687-99. PubMed ID: 21219128
[TBL] [Abstract][Full Text] [Related]
10. Differential responses of human neural and hematopoietic stem cells to ethanol exposure.
Hao HN; Parker GC; Zhao J; Barami K; Lyman WD
J Hematother Stem Cell Res; 2003 Aug; 12(4):389-99. PubMed ID: 12965076
[TBL] [Abstract][Full Text] [Related]
11. The stem cell marker nestin predicts poor prognosis in human melanoma.
Piras F; Perra MT; Murtas D; Minerba L; Floris C; Maxia C; Demurtas P; Ugalde J; Ribatti D; Sirigu P
Oncol Rep; 2010 Jan; 23(1):17-24. PubMed ID: 19956860
[TBL] [Abstract][Full Text] [Related]
12. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
[TBL] [Abstract][Full Text] [Related]
13. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
[TBL] [Abstract][Full Text] [Related]
14. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
[TBL] [Abstract][Full Text] [Related]
15. Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways.
Cheeran MC; Hu S; Ni HT; Sheng W; Palmquist JM; Peterson PK; Lokensgard JR
J Neurosci Res; 2005 Dec; 82(6):839-50. PubMed ID: 16273540
[TBL] [Abstract][Full Text] [Related]
16. CD45+/CD133+ positive cells expanded from umbilical cord blood expressing PDX-1 and markers of pluripotency.
Pessina A; Bonomi A; Sisto F; Baglio C; Cavicchini L; Ciusani E; Coccé V; Gribaldo L
Cell Biol Int; 2010 Aug; 34(8):783-90. PubMed ID: 20397976
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a GM7 glioblastoma cell line showing CD133 positivity and both cytoplasmic and nuclear localization of nestin.
Loja T; Chlapek P; Kuglik P; Pesakova M; Oltova A; Cejpek P; Veselska R
Oncol Rep; 2009 Jan; 21(1):119-27. PubMed ID: 19082452
[TBL] [Abstract][Full Text] [Related]
18. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
[TBL] [Abstract][Full Text] [Related]
19. Isolation and partial characterization of a new human glioblastoma cell line.
Brehar FM; Bleotu C; Stefan LM; Buzgariu W; Chivu M; Utoiu E; Matei L; Ciurea AV; Tascu A
Chirurgia (Bucur); 2009; 104(4):453-61. PubMed ID: 19886054
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of CD133+ stem cells from amyotrophic lateral sclerosis patients into preneuron cells.
González-Garza MT; Martínez HR; Caro-Osorio E; Cruz-Vega DE; Hernández-Torre M; Moreno-Cuevas JE
Stem Cells Transl Med; 2013 Feb; 2(2):129-35. PubMed ID: 23341441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
